Pharmacological study of the safety, efficacy, and potential of M201-A on paroxysmal and persistent atrial fibrillation
- DOI
- 10.1016/j.jpet.2025.103652
- Published
- 2025-08
- Container
- The Journal of Pharmacology and Experimental Therapeutics
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.jpet.2025.103652,
title = {Pharmacological study of the safety, efficacy, and potential of M201-A on paroxysmal and persistent atrial fibrillation},
author = {Noboru Kaneko and Godfrey L. Smith and Christopher M. Loughrey and Ryuko Matsuda and Kengo Kusano and Yuko Inoue and Naoyuki Otani and Masashi Toda and Kayley Scott and Ana Da Silva Costa and Sara Dobi and Priyanka Saxena and Patrick B. Mark and Makoto Shinozaki and Ryuichi Kambayashi and Alexandra Riddell and Elspeth B. Elliott and Charlotte S. McCarroll and Takeshi Kitai and Tomoko Hasunuma and Ken Shimamoto and Toshiya Sakai and Masahiko Nakamura and Migaku Kikuchi and Shigeru Toyoda and Tetsuya Ishikawa and Koichiro Kumagai and Isao Taguchi and Atsushi Sugiyama and Yasuki Kihara and Toshihiko Fujiwara and Yuji Kumagai and Kunio Iwata},
year = {2025},
journal = {The Journal of Pharmacology and Experimental Therapeutics},
doi = {10.1016/j.jpet.2025.103652},
url = {https://doi.org/10.1016/j.jpet.2025.103652}
}RIS
TY - JOUR TI - Pharmacological study of the safety, efficacy, and potential of M201-A on paroxysmal and persistent atrial fibrillation AU - Noboru Kaneko AU - Godfrey L. Smith AU - Christopher M. Loughrey AU - Ryuko Matsuda AU - Kengo Kusano AU - Yuko Inoue AU - Naoyuki Otani AU - Masashi Toda AU - Kayley Scott AU - Ana Da Silva Costa AU - Sara Dobi AU - Priyanka Saxena AU - Patrick B. Mark AU - Makoto Shinozaki AU - Ryuichi Kambayashi AU - Alexandra Riddell AU - Elspeth B. Elliott AU - Charlotte S. McCarroll AU - Takeshi Kitai AU - Tomoko Hasunuma AU - Ken Shimamoto AU - Toshiya Sakai AU - Masahiko Nakamura AU - Migaku Kikuchi AU - Shigeru Toyoda AU - Tetsuya Ishikawa AU - Koichiro Kumagai AU - Isao Taguchi AU - Atsushi Sugiyama AU - Yasuki Kihara AU - Toshihiko Fujiwara AU - Yuji Kumagai AU - Kunio Iwata PY - 2025 JO - The Journal of Pharmacology and Experimental Therapeutics DO - 10.1016/j.jpet.2025.103652 UR - https://doi.org/10.1016/j.jpet.2025.103652 ER -
APA
Kaneko, N., Smith, G. L., Loughrey, C. M., Matsuda, R., Kusano, K., Inoue, Y., Otani, N., Toda, M., Scott, K., Costa, A. D. S., Dobi, S., Saxena, P., Mark, P. B., Shinozaki, M., Kambayashi, R., Riddell, A., Elliott, E. B., McCarroll, C. S., Kitai, T., Hasunuma, T., Shimamoto, K., Sakai, T., Nakamura, M., Kikuchi, M., Toyoda, S., Ishikawa, T., Kumagai, K., Taguchi, I., Sugiyama, A., Kihara, Y., Fujiwara, T., Kumagai, Y., & Iwata, K. (2025). Pharmacological study of the safety, efficacy, and potential of M201-A on paroxysmal and persistent atrial fibrillation. The Journal of Pharmacology and Experimental Therapeutics. https://doi.org/10.1016/j.jpet.2025.103652
Source records
- crossref · retrieved 2026-09-26T00:52:29.377Z